Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of June 2026, specifically dated June 2, 2026. The report serves to disclose a corporate action regarding a reverse share split intended to support compliance with Nasdaq listing requirements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notice of a capital structure change rather than a financial performance report.
Material Changes
On June 2, 2026, the Company announced a 1-for-30 reverse share split. This action is designed to increase the per-share trading price to meet Nasdaq compliance standards. No other material financial changes were reported in this specific filing.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the reverse share split. The filing does not contain updated financial guidance, operational outlook, or a discussion of specific risks beyond the implied risk of non-compliance with Nasdaq listing rules that necessitated the split. No unusual items or contingencies were disclosed.
Investor Verification Checklist
- Verify the effective date and record date for the 1-for-30 reverse share split.
- Confirm the current Nasdaq compliance status of Icecure Medical Ltd. following the announcement.
- Review the press release (Exhibit 99.1) for details on how the split affects outstanding share count and per-share price.
- Check subsequent filings for updated financial statements reflecting the post-split capital structure.